{
    "ticker": "ETON",
    "name": "Eton Pharmaceuticals, Inc.",
    "description": "Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative pharmaceutical products to meet the needs of patients and healthcare providers. Founded in 2017, Eton aims to deliver high-quality medications that address unmet medical needs in various therapeutic areas. The company leverages its proprietary drug development platform to create new formulations and enhance existing products, particularly those that can improve patient outcomes. Eton's lead product, PediaDose, is designed for children, offering a more palatable and easier-to-administer formulation of medications. The company is committed to addressing the challenges faced in pediatric medication administration, ensuring that young patients receive the appropriate dosages in a safe and effective manner. Eton's pipeline includes several product candidates that are in various stages of development, focusing on delivering solutions that can improve compliance and overall treatment efficacy. Eton's mission is to provide innovative therapeutic solutions that enhance the quality of life for patients while also ensuring accessibility and affordability.",
    "industry": [
        "Pharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Lake Forest, Illinois, USA",
    "founded": "2017",
    "website": "https://etonpharma.com",
    "ceo": "Sean Brynjelsen",
    "social_media": {
        "twitter": "https://twitter.com/EtonPharma",
        "linkedin": "https://www.linkedin.com/company/eton-pharmaceuticals"
    },
    "investor_relations": "https://etonpharma.com/investors",
    "key_executives": [
        {
            "name": "Sean Brynjelsen",
            "position": "CEO"
        },
        {
            "name": "Danielle DeMarco",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pediatric Medications",
            "products": [
                "PediaDose"
            ]
        },
        {
            "category": "Pharmaceutical Products",
            "products": [
                "Innovative Formulations"
            ]
        }
    ],
    "seo": {
        "meta_title": "Eton Pharmaceuticals, Inc. | Innovative Pharmaceutical Solutions",
        "meta_description": "Learn about Eton Pharmaceuticals, Inc., a leader in developing innovative pharmaceutical products for patients. Explore our mission and product offerings.",
        "keywords": [
            "Eton Pharmaceuticals",
            "Pediatric Medications",
            "Pharmaceutical Innovation",
            "Healthcare Solutions",
            "PediaDose"
        ]
    },
    "faq": [
        {
            "question": "What does Eton Pharmaceuticals specialize in?",
            "answer": "Eton Pharmaceuticals specializes in developing and commercializing innovative pharmaceutical products, particularly for pediatric patients."
        },
        {
            "question": "Who is the CEO of Eton Pharmaceuticals?",
            "answer": "Sean Brynjelsen is the CEO of Eton Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Eton Pharmaceuticals headquartered?",
            "answer": "Eton Pharmaceuticals is headquartered in Lake Forest, Illinois, USA."
        },
        {
            "question": "What is Eton's lead product?",
            "answer": "Eton's lead product is PediaDose, designed specifically for children to improve medication administration."
        },
        {
            "question": "When was Eton Pharmaceuticals founded?",
            "answer": "Eton Pharmaceuticals was founded in 2017."
        }
    ],
    "competitors": [
        "PTCT",
        "AMGN",
        "ALNY"
    ],
    "related_stocks": [
        "VRTX",
        "GILD",
        "BIIB",
        "ABBV"
    ]
}